Krieger T, Pearson I, Bell J, Doherty J, Robbins P. Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment. Diagn Pathol. 2020 Jan 30;15(1):6. doi: 10.1186/s13000-020-0927-9
Fernandez MM, Wang J, Ye X, Kwong WJ, Sherif B, Hogue S, Sherrill B. Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score slanted greater than or equal to 2. SAGE Open Med. 2015 Dec. doi: 10.1177/2050312115613350
López MV, Rivero E, Serra C, Campo M, Raurich M, Bonfill X. Health survey in health care professionals in Barcelona. Arch Prev Riesgos Laborales. 1998;1(2):55-62.
Cann CI, Fried MP, Rothman KJ. Epidemiology of squamous-cell cancer of the head and neck. Otolaryngol Clin N Am. 1985 Aug 1;18(3):367-88.